openPR Logo
Press release

Genome Editing Market on the Rise: Key Players, Innovations, and Investment Prospects (2024-2030)

๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ

The ๐†๐ž๐ง๐จ๐ฆ๐ž ๐„๐๐ข๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ valued at USD 7.23 billion in 2023, is projected to experience robust growth, with a Compound Annual Growth Rate (CAGR) of 15.8%. This growth trajectory is expected to propel the market to nearly USD 20.19 billion by 2030, highlighting the transformative potential of genome editing technologies across various sectors.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Genome editing, a cutting-edge technology, has ushered in a new era of precision in biotechnology. The incorporation of CRISPR technology, in particular, has revolutionized research, medicine, and agriculture, positioning the Genome Editing Market for sustained growth. The ability to precisely alter genetic material holds enormous potential for applications ranging from developing genetically modified crops to advancing therapeutic interventions. The COVID-19 pandemic underscored the importance of rapid and accurate diagnostics, further reinforcing the value of genome editing technologies like CRISPR. As the demand for synthetic genes, innovative applications, and government support continues to grow, the Genome Editing Market is set to make pioneering contributions across various domains.

๐†๐ž๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/request-sample/2747/

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‚๐จ๐ฏ๐ž๐ซ๐š๐ ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ:

โ€ข Base Year: 2023
โ€ข Forecast Period: 2024-2030
โ€ข Historical Data: 2018-2023
โ€ข Market Size in 2023: USD 7.23 Billion
โ€ข Forecast Period CAGR: 15.8%
โ€ข Market Size by 2030: USD 20.19 Billion
โ€ข Segments Covered:
o By Technology: CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs, Others
o By Application: Cell line engineering, Animal genetic engineering, Plant genetic engineering, Others
o By End-user: Biotech and pharma companies, Contract research organizations (CROs), Research institutes

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Œ๐ž๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ:

The research methodology for analyzing the Genome Editing Market involves a combination of primary and secondary data sources. Primary data collection includes interviews with industry experts, surveys, and insights from leading market players. Secondary research involves studying industry reports, publications, company filings, and other reputable sources. This comprehensive approach ensures the accuracy and relevance of the market analysis, providing a detailed understanding of market trends, drivers, and challenges.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐œ๐จ๐ฉ๐ž:

The scope of the Genome Editing Market encompasses the technological advancements, application areas, and regional dynamics that shape the market landscape. Key technologies such as CRISPR/Cas9, TALENs, and Zinc Finger Nucleases are central to this market, with applications spanning from cell line engineering to animal and plant genetic engineering. The market's scope also includes an analysis of the end-user segments, including biotech and pharmaceutical companies, contract research organizations (CROs), and research institutes.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐Ž๐›๐ฃ๐ž๐œ๐ญ๐ข๐ฏ๐ž:

The primary objective of the Genome Editing Market report is to provide a comprehensive analysis of the market's current state and future potential. The report aims to offer insights into the key drivers, restraints, and opportunities that will shape the market's growth. It also seeks to provide a detailed segmentation analysis, highlighting the performance of various market segments. Additionally, the report offers regional insights, showcasing the market dynamics across different geographies.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

North America dominated the Genome Editing Market in 2023, driven by the rising prevalence of rare diseases in the U.S. and Canada. The region's robust healthcare infrastructure, coupled with significant investment in research and development, supports the growth of genome editing technologies. The presence of leading industry players further enhances the market's growth prospects in North America. The Asia Pacific region is expected to be the second-largest market, with emerging countries like China, Japan, and India playing a crucial role. These countries are witnessing a surge in research organizations and increased focus on developing gene-editing techniques, contributing to regional market growth.

๐†๐ž๐ญ ๐š ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐๐ƒ๐…: https://www.maximizemarketresearch.com/request-sample/2747/

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

1. ๐๐š๐ฌ๐ž๐ ๐จ๐ง ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ:

o CRISPR/Cas9: Dominates the technology segment due to its simplicity, cost-effectiveness, and versatility. The increasing use of CRISPR/Cas9 in genome investigations for identifying genetic disorders and drug discovery continues to drive demand. Companies like Caribou Biosciences, Takara Bio, and Thermo Fisher Scientific are at the forefront of advancing this technology.

2. ๐๐š๐ฌ๐ž๐ ๐จ๐ง ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง:

o Cell-line Engineering: Leads the application segment, particularly for stem cell-based therapies. Innovations in genome editing techniques, such as ZFNs, CRISPR/Cas, and TALENs, have reduced costs and streamlined the process, enabling significant advancements in genetic manipulation and its application in induced pluripotent stem cells (iPSCs).

3. ๐๐š๐ฌ๐ž๐ ๐จ๐ง ๐„๐ง๐-๐”๐ฌ๐ž๐ซ:

o Biotech and Pharma Companies: These companies are the primary users of genome editing technologies, leveraging them for drug discovery and therapeutic development. Contract research organizations (CROs) and research institutes also play vital roles in the adoption and development of these technologies.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

โ€ข North America: Editas Medicine, Inc., Intellia Therapeutics, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Precision Biosciences, Inc.
โ€ข Europe: Intellia Therapeutics, Inc., Cellectis S.A., Horizon Discovery Group plc.
โ€ข Asia Pacific: BGI Genomics Co., Ltd, ToolGen, Inc., GenScript Biotech Corporation, Takara Bio Inc., Biocytogen.
โ€ข Dominant Global Players: Thermo Fisher Scientific, Merck KGaA (Sigma-Aldrich), Lonza, Synthego.

๐“๐š๐›๐ฅ๐ž ๐จ๐Ÿ ๐‚๐จ๐ง๐ญ๐ž๐ง๐ญ:

1. Introduction
2. Market Overview
3. Market Dynamics
o Drivers
o Restraints
o Opportunities
4. Market Segmentation
o By Technology
o By Application
o By End-User
5. Regional Analysis
o North America
o Europe
o Asia Pacific
o Middle East & Africa
o South America
6. Competitive Landscape
o Key Players
o Market Share Analysis
7. Market Forecast
8. Conclusion
9. Appendix

๐‚๐ก๐ž๐œ๐ค ๐Ž๐ฎ๐ญ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.maximizemarketresearch.com/market-report/genome-editing-market/2747/

๐Š๐ž๐ฒ ๐๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ:

1. What are the main segments covered in the Genome Editing Market report?
2. Which region is expected to dominate the Genome Editing Market by 2030?
3. What are the growth prospects for the Genome Editing Market during the forecast period?
4. What are the major challenges facing the Genome Editing Market?
5. How is CRISPR technology shaping the future of the Genome Editing Market?

๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

1. Comprehensive market analysis covering key trends and dynamics.
2. Detailed segmentation analysis by technology, application, and end-user.
3. Regional insights highlighting market performance across geographies.
4. Competitive landscape analysis with profiles of key players.
5. Forecast data and future market projections through 2030.

๐Ž๐ฎ๐ซ ๐€๐๐๐ซ๐ž๐ฌ๐ฌ:

๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐๐ฏ๐ญ. ๐‹๐ญ๐.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genome Editing Market on the Rise: Key Players, Innovations, and Investment Prospects (2024-2030) here

News-ID: 3626520 • Views: โ€ฆ

More Releases from Maximize Market Research Pvt. Ltd.

Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR - Clinical Trials Market Forecast Insights
Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR โ€ฆ
According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR. โ–บ Get a sample of theโ€ฆ
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5.16% Driven
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 โ€ฆ
Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn. Turbo Trainer Market Overview: The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essentialโ€ฆ
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of 7% Driven
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of โ€ฆ
Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million. Sodium Acetate Market Overview: The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, isโ€ฆ
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR -
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire โ€ฆ
According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres. โ–บ Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/ โ™ฆ Key Highlights Market sizeโ€ฆ

All 5 Releases


More Releases for Genome

Emerging Trends Influencing The Growth Of The Genome Editing/Genome Engineering โ€ฆ
The Genome Editing/Genome Engineering Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genome Editing/Genome Engineering Market Size Expected to Be by 2034? The size of the genome editing/genome engineering market has expanded swiftly in the past few years. Forecasts suggest the growthโ€ฆ
Genome Editing/Genome Engineering Market 2023 - Size, Share, Segments, Data, Gro โ€ฆ
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Genome Editing Or Genome Engineering Market Size, Growth Rate, And Forecast The global genome editing or genome engineering market size is expected to grow from $6.11 billion in 2022 to $7.20 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The genome editing or genomeโ€ฆ
Genome Editing & Genome Engineering Industry Research Report, Growth, Trends 202 โ€ฆ
Genome Editing & Genome Engineering Market 2028 Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments. Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Genome Editing & Genome Engineering estimated at US$ 3953 million in the year 2022, is projected to reach a revised size of US$ 6739.8 million by 2028,โ€ฆ
Genome Editing/Genome Engineering Market Size - Industry Analysis Report 2021
Genome Editing/Genome Engineering Market Size, Capacity, Trends, Outlook, Research, Analysis, Growth | Industry Report 2021 Market Research Report to Itโ€™s a Database. Inquire Before Buying @ http://bit.ly/2uh3G7k The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with theโ€ฆ
Genome Editing/Genome Engineering Market to experience hike in growth by 2024
Zion Market Research, the market research group announced the analysis report titled โ€˜Genome Editing/Genome Engineering Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016โ€“2024โ€™ Global Genome Editing/Genome Engineering Market: Overview Genome editing/genome engineering refers to the techniques and strategies in which the DNA is deleted, replaced or inserted in the living organismโ€™s genome with the help of molecular scissors or engineered nucleases. It is one of the active fields ofโ€ฆ
Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022
Qyresearchreports include new market research report "Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022" to its huge collection of research reports. The term healthcare has held a consistent definition over the many years of its development so far. However, the point at which this industry resides now is extremely advanced than the point it was at a few decades ago, thanks to the recent boom in technological advancements, theโ€ฆ